E. T. Wang, R. Sandberg, S. Luo, I. Khrebtukova, L. Zhang et al., Alternative isoform regulation in human tissue transcriptomes, Nature, vol.456, pp.470-476, 2008.

T. W. Nilsen and B. R. Graveley, Expansion of the eukaryotic proteome by alternative splicing, Nature, vol.463, pp.457-463, 2010.

M. Dutertre, G. Sanchez, D. Cian, M. Barbier, J. Dardenne et al., Cotranscriptional exon skipping in the genotoxic stress response, Nat Struct Mol Biol, vol.17, pp.1358-1366, 2010.

M. Hallegger, M. Llorian, and C. Smith, Alternative splicing: global insights, FEBS J, vol.277, pp.856-866, 2010.

C. J. David and J. L. Manley, Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged, Genes Dev, vol.24, pp.2343-2364, 2010.

C. Akgul, D. A. Moulding, and S. W. Edwards, Alternative splicing of Bcl-2-related genes: functional consequences and potential therapeutic applications, Cell Mol Life Sci, vol.61, pp.2189-2199, 2004.

K. Miura, W. Fujibuchi, and M. Unno, Splice variants in apoptotic pathway, Exp Oncol, vol.34, pp.212-217, 2012.

C. Schwerk and K. Schulze-osthoff, Regulation of apoptosis by alternative pre-mRNA splicing, Mol Cell, vol.19, pp.1-13, 2005.

L. E. Maquat, Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics, Nat Rev Mol Cell Biol, vol.5, pp.89-99, 2004.

O. Isken and L. E. Maquat, The multiple lives of NMD factors: balancing roles in gene and genome regulation, Nat Rev Genet, vol.9, pp.699-712, 2008.

P. J. Gardina, T. A. Clark, B. Shimada, M. K. Staples, Q. Yang et al., Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array, BMC Genomics, vol.7, p.325, 2006.

W. Mojica and L. Hawthorn, Normal colon epithelium: a dataset for the analysis of gene expression and alternative splicing events in colon disease, BMC Genomics, vol.11, p.5, 2010.

J. Xuan, Y. Yu, T. Qing, L. Guo, and L. Shi, Next-generation sequencing in the clinic: promises and challenges, Cancer Lett, vol.340, pp.248-295, 2012.

Z. Wang, M. Gerstein, and M. Snyder, RNA-Seq: a revolutionary tool for transcriptomics, Nat Rev Genet, vol.10, pp.57-63, 2009.

K. Mutz, A. Heilkenbrinker, M. Lönne, J. Walter, and F. Stahl, Transcriptome analysis using next-generation sequencing, Curr Opin Biotechnol, vol.24, pp.22-30, 2013.

R. Lindner and C. C. Friedel, A comprehensive evaluation of alignment algorithms in the context of RNA-Seq, PLoS ONE, vol.7, p.52403, 2012.

C. Trapnell, D. G. Hendrickson, M. Sauvageau, L. Goff, J. L. Rinn et al., Differential analysis of gene regulation at transcript resolution with RNA-seq, Nat Biotechnol, vol.31, pp.46-53, 2012.

W. Xu, J. Seok, M. N. Mindrinos, A. C. Schweitzer, H. Jiang et al., Human transcriptome array for highthroughput clinical studies, Proc Natl Acad Sci, vol.108, pp.3707-3712, 2011.

A. M. Glas, A. Floore, L. Delahaye, A. T. Witteveen, R. Pover et al., Converting a breast cancer microarray signature into a high-throughput diagnostic test, BMC Genomics, vol.7, p.278, 2006.

E. H. Romond, E. A. Perez, J. Bryant, V. J. Suman, C. E. Geyer et al., Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer, N Engl J Med, vol.353, pp.1673-1684, 2005.

M. J. Piccart-gebhart, M. Procter, B. Leyland-jones, A. Goldhirsch, M. Untch et al., Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer, N Engl J Med, vol.353, pp.1659-1672, 2005.

Y. A. Muller, Y. Chen, H. W. Christinger, B. Li, B. C. Cunningham et al., de Vos AM: VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 A resolution and mutational analysis of the interface, Structure, vol.6, pp.1153-1167, 1998.

C. J. Robinson and S. E. Stringer, The splice variants of vascular endothelial growth factor (VEGF) and their receptors, J Cell Sci, vol.114, pp.853-865, 2001.

D. O. Bates, T. Cui, J. M. Doughty, M. Winkler, M. Sugiono et al., VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma, Cancer Res, vol.62, pp.4123-4131, 2002.

M. R. Ladomery, S. J. Harper, and D. O. Bates, Alternative splicing in angiogenesis: the vascular endothelial growth factor paradigm, Cancer Lett, vol.249, pp.133-142, 2007.

G. Merdzhanova, S. Gout, M. Keramidas, V. Edmond, J. L. Coll et al., The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo, Oncogene, vol.29, pp.5392-5403, 2010.

S. Lin, G. Coutinho-mansfield, D. Wang, S. Pandit, and X. Fu, The splicing factor SC35 has an active role in transcriptional elongation, Nat Struct Mol Biol, vol.15, pp.819-826, 2008.

S. Gout, E. Brambilla, A. Boudria, R. Drissi, S. Lantuejoul et al., Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma, PLoS ONE, vol.7, p.46539, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-02337424

J. Wang and J. L. Manley, Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways, RNA, vol.1, pp.335-346, 1995.

X. Wang and M. J. Cairns, Gene set enrichment analysis of RNA-Seq data: integrating differential expression and splicing, BMC Bioinforma, vol.14, p.16, 2013.

X. Ma and X. Zhang, NURD: an implementation of a new method to estimate isoform expression from non-uniform RNA-seq data, BMC Bioinforma, vol.14, p.220, 2013.

F. A. Rahman, N. Aziz, and D. Coverley, Differential detection of alternatively spliced variants of Ciz1 in normal and cancer cells using a custom exon-junction microarray, BMC Cancer, vol.10, p.482, 2010.

D. O. Bates and S. J. Harper, Therapeutic potential of inhibitory VEGF splice variants, Future Oncol, vol.1, pp.467-473, 2005.

S. J. Harper and D. O. Bates, VEGF-A splicing: the key to anti-angiogenic therapeutics?, Nat Rev Cancer, vol.8, pp.880-887, 2008.

D. G. Nowak, E. M. Amin, E. S. Rennel, C. Hoareau-aveilla, M. Gammons et al., Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis, J Biol Chem, vol.285, pp.5532-5540, 2010.

Y. Qiu, C. Hoareau-aveilla, S. Oltean, S. J. Harper, and D. O. Bates, The antiangiogenic isoforms of VEGF in health and disease, Biochem Soc Trans, vol.37, pp.1207-1213, 2009.

C. Hilmi, M. Guyot, and G. Pages, VEGF spliced variants: possible role of antiangiogenesis therapy, J Nucleic Acids, p.162692, 2012.

A. Guillaudeau, K. Durand, B. Bessette, A. Chaunavel, I. Pommepuy et al., EGFR soluble isoforms and their transcripts are expressed in meningiomas, PLoS One, vol.7, p.37204, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00872638

H. Wang, M. Zhou, B. Shi, Q. Zhang, H. Jiang et al., Identification of an exon 4-deletion variant of epidermal growth factor receptor with increased metastasis-promoting capacity, Neoplasia, vol.13, pp.461-471, 2011.

M. Imielinski, H. Berger-alice, H. Peter, S. Hernandez, B. et al., Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing, Cell, vol.150, pp.1107-1120, 2012.

A. Varey, E. S. Rennel, Y. Qiu, H. S. Bevan, R. M. Perrin et al., VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro-and antiangiogenic VEGF-A isoforms has implications for therapy, Br J Cancer, vol.98, pp.1366-1379, 2008.

M. Lagarrigue, T. Alexandrov, G. Dieuset, A. Perrin, R. Lavigne et al., New analysis workflow for MALDI imaging mass spectrometry: application to the discovery and identification of potential markers of childhood absence epilepsy, J Proteome Res, vol.11, pp.5453-5463, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00877728

S. Solier, A. Lansiaux, E. Logette, J. Wu, J. Soret et al., Topoisomerase I and II inhibitors control, p.2
URL : https://hal.archives-ouvertes.fr/hal-02262420

. Pre-messenger, RNA splicing in human cells, Mol Cancer Res, vol.2, pp.53-61, 2004.

C. Salon, B. Eymin, O. Micheau, L. Chaperot, J. Plumas et al., E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIPshort, Cell Death Differ, vol.13, pp.260-272, 2006.

C. Salon, G. Merdzhanova, C. Brambilla, E. Brambilla, S. Gazzeri et al., E2F1, Skp2 and cyclin E oncoproteins are upregulated and directly correlated in high-grade neuroendocrine lung tumors, Oncogene, vol.26, pp.6927-6936, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00173067

S. Gandoura, E. Weiss, P. Rautou, M. Fasseu, T. Gustot et al., Gene-and exon-expression profiling reveals an extensive LPS-induced response in immune cells in patients with cirrhosis, J Hepatol, vol.58, pp.936-948, 2013.

E. Wang, V. Aslanzadeh, F. Papa, H. Zhu, P. De-la-grange et al., Global profiling of alternative splicing events and gene expression regulated by hnRNPH/F, PLoS ONE, vol.7, p.51266, 2012.

K. J. Livak and T. D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2 ? ??CT method, Methods, vol.25, pp.402-408, 2001.

. Pesson, A dedicated microarray for in-depth analysis of pre-mRNA splicing events: application to the study of genes involved in the response to targeted anticancer therapies, Molecular Cancer, vol.13, p.9, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-00935318